New COVID Treatments Face FDA, Commercial Barriers Despite Ongoing Need

Sponsors want more endpoint clarity as current state of government pandemic response, along with scientific and regulatory hurdles, is constraining efforts to refill a shrinking COVID medicine cabinet and could create vulnerabilities for future pandemics.

empty toolbox
The COVID therapeutic toolbox is getting emptier. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards